Erythropoietic stimulating factors and anemia: Studies recommend prudence;Factores estimulantes de eritropoyesis y anemia en pacientes con cáncer: Los estudios indican prudencia

Farmacia Hospitalaria

Volumn 29, Issue 2, 2005, Pages 73-74

  Clopes Estela A ^a   Mesia Nin R ^a  

^a CATALAN INSTITUTE OF ONCOLOGY   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANEMIA; CANCER PATIENT; CANCER RESEARCH; CANCER THERAPY; EDITORIAL; ERYTHROPOIESIS; HUMAN; MEDICAL SOCIETY; ONCOLOGY;

EID: 20944446674     PISSN: 11306343     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1130-6343(05)73641-2     Document Type: Editorial

References (6)

1. Leyland B. Breast cancer trial erythropoietin terminated unexpectedly. Lancet Oncol 2003; 4: 459-60.
2. Henke M, Laszig R, Rübe C, Schafer U, Haase KD, Schilcher B, et al. Erythropoetin to treat head and neck cancer patients with anaemia undergoing radiotherapy: randomised, double-blind, placebo-controlled trial. Lancet 2003; 362: 1255-60.
3. Machtay M, Pajak T, Suntharalingam M, Hershock D, Stripp D, Cmelak A, et al. Definitive radiotherapy +/- erythropoietin for squamous cell carcinoma of the head and neck: preliminary report of RTOG 99-03. Int J Radiat Oncol Biol Phys 2004; 60 (Supl. 1): S132.
4. Acs G, Acs P, Beckwith S, Pitts RL, Clements E, Wong K, et al. Erythropoietin and erytropoietin receptor expression in human cancer. Can Res 2001; 61: 3561-5.
5. Arcasoy MO, Amin K, Chou SC, Haroon Z, Varia M, Raleigh JA. Erythropoietin and erythropoietin receptor expression in head and neck cancer: relationship to tumor hypoxia. Clin Cancer Res 2005; 11: 20-7.
6. Bokemayer C, Aapro MS, Courdi A, Foubert J, Link H, Österborg A, et al. EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancer. Eur J Can 2004; 40: 2201-16.